Paper30867685
MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1.
Xu H and 5 others. Exp Ther Med, 2019. Cited by 22 papers, by iCite. Retracted.
Cite this record
ConductScience Library. MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1. Papers, record 30867685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30867685
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Retracted by | 41158140 | [Retracted] MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1. | https://conductscience.org/library/papers/41158140 |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11424081 | Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. | J Cell Physiol | 2001 | https://conductscience.org/library/papers/11424081 | PubMed |
| 2 | 11846609 | Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. | Methods | 2001 | https://conductscience.org/library/papers/11846609 | PubMed |
| 3 | 14744438 | MicroRNAs: genomics, biogenesis, mechanism, and function. | Cell | 2004 | https://conductscience.org/library/papers/14744438 | PubMed |
| 4 | 15538371 | A pancreatic islet-specific microRNA regulates insulin secretion. | Nature | 2004 | https://conductscience.org/library/papers/15538371 | PubMed |
| 5 | 19789312 | MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19789312 | PubMed |
| 6 | 20607723 | Sp1 upregulates the four and half lim 2 (FHL2) expression in gastrointestinal cancers through transcription regulation. | Mol Carcinog | 2010 | https://conductscience.org/library/papers/20607723 | PubMed |
| 7 | 21148309 | microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21148309 | PubMed |
| 8 | 21945323 | miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21945323 | PubMed |
| 9 | 22367141 | MicroRNA and its roles in esophageal cancer. | Med Sci Monit | 2012 | https://conductscience.org/library/papers/22367141 | PubMed |
| 10 | 22910036 | Oesophageal cancer survival in Europe: a EUROCARE-4 study. | Cancer Epidemiol | 2012 | https://conductscience.org/library/papers/22910036 | PubMed |
| 11 | 22917659 | A global assessment of the oesophageal adenocarcinoma epidemic. | Gut | 2013 | https://conductscience.org/library/papers/22917659 | PubMed |
| 12 | 23374478 | Oesophageal carcinoma. | Lancet | 2013 | https://conductscience.org/library/papers/23374478 | PubMed |
| 13 | 24166096 | The emerging role of miR-375 in cancer. | Int J Cancer | 2014 | https://conductscience.org/library/papers/24166096 | PubMed |
| 14 | 25097879 | The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis. | ScientificWorldJournal | 2014 | https://conductscience.org/library/papers/25097879 | PubMed |
| 15 | 25242378 | Cancer survival in China, 2003-2005: a population-based study. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25242378 | PubMed |
| 16 | 25320104 | Global incidence of oesophageal cancer by histological subtype in 2012. | Gut | 2015 | https://conductscience.org/library/papers/25320104 | PubMed |
| 17 | 25393971 | Sp1 and the 'hallmarks of cancer'. | FEBS J | 2015 | https://conductscience.org/library/papers/25393971 | PubMed |
| 18 | 25651787 | Global cancer statistics, 2012. | CA Cancer J Clin | 2015 | https://conductscience.org/library/papers/25651787 | PubMed |
| 19 | 26309536 | MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26309536 | PubMed |
| 20 | 26550114 | Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26550114 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38192621 | Active components of Solanum nigrum and their antitumor effects: a literature review. | Front Oncol | 2023 | https://conductscience.org/library/papers/38192621 | PubMed |
| 37035550 | fRNC: Uncovering the dynamic and condition-specific RBP-ncRNA circuits from multi-omics data. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/37035550 | PubMed |
| 36176382 | Prognostic value of micro-RNA 375, 133, 143, 145 in esophageal carcinoma: A systematic review and meta-analysis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36176382 | PubMed |
| 36051876 | Survival estimation in patients with stomach and esophageal carcinoma using miRNA expression profiles. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/36051876 | PubMed |
| 35922756 | MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. | Mol Med | 2022 | https://conductscience.org/library/papers/35922756 | PubMed |
| 35790503 | A novel circ_0000654/miR-375/E2F3 ceRNA network in esophageal squamous cell carcinoma. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/35790503 | PubMed |
| 35082400 | Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy. | Cancer Gene Ther | 2022 | https://conductscience.org/library/papers/35082400 | PubMed |
| 34699320 | E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375. | Bioengineered | 2021 | https://conductscience.org/library/papers/34699320 | PubMed |
| 33807389 | miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33807389 | PubMed |
| 33042419 | lncRNA-SNHG17 promotes colon adenocarcinoma progression and serves as a sponge for miR-375 to regulate CBX3 expression. | Am J Transl Res | 2020 | https://conductscience.org/library/papers/33042419 | PubMed |
| 32801782 | Circular RNA circLPAR3 Facilitates Esophageal Squamous Cell Carcinoma Progression Through Upregulating HMGB1 via Sponging miR-375/miR-433. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32801782 | PubMed |
| 32644005 | MiR-375-3p regulates rat pulmonary microvascular endothelial cell activity by targeting Notch1 during hypoxia. | J Int Med Res | 2020 | https://conductscience.org/library/papers/32644005 | PubMed |
| 32273764 | Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32273764 | PubMed |
| 31939714 | PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1. | Cancer Biol Ther | 2020 | https://conductscience.org/library/papers/31939714 | PubMed |
| 31681610 | The Reciprocal Interaction Between LncRNA CCAT1 and miR-375-3p Contribute to the Downregulation of IRF5 Gene Expression by Solasonine in HepG2 Human Hepatocellular Carcinoma Cells. | Front Oncol | 2019 | https://conductscience.org/library/papers/31681610 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EEF1A1 | 1915 | PubTator's text mining | https://conductscience.org/library/genes/1915 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| MIR205 | 406988 | PubTator's text mining | https://conductscience.org/library/genes/406988 | NCBI Gene |
| MIR375 | 494324 | PubTator's text mining | https://conductscience.org/library/genes/494324 | NCBI Gene |
| SP1 | 6667 | PubTator's text mining | https://conductscience.org/library/genes/6667 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30867685
GET https://conductscience.org/api/papers/v1/30867685/references?page=2